Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 664 of 1,261
  1. US 9492564

    Dual specific immunotoxin for brain tumor therapy

    The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  2. US 9493493

    Nucleotide analogs

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  3. US 9492405

    Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  4. US 9492480

    Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  5. US 9492538

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  6. US 9493432

    Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  7. US 9493496

    Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same

    OCEAN UNIVERSITY OF CHINA · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  8. US 9493552

    Therapeutic biologic for treatment of hepatocellular carcinoma

    China Synthetic Rubber Corporation · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  9. US 9493564

    CD86 antagonist multi-target binding proteins

    Aptevo Research and Development LLC · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  10. US 9493757

    Modified factor VII or factor VIIa polypeptides

    Regents of the University of Minnesota · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  11. US 9492443

    Abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  12. US 9492415

    Methods of treating Parkinson's disease using viral vectors

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  13. US 9491934

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  14. US 9492378

    Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  15. US 9493833

    Methods for preventing induced synthesis of proteasomes in human cells

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  16. US 9493770

    Method for identifying antibiotic targets by complemented sequencing

    DISCUVA LIMITED · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  17. US 9493760

    Fungal-specific metalloproteases and uses thereof

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  18. US 9493845

    Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

    PTC THERAPEUTICS, INC. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  19. US 9493750

    DNA-binding proteins and uses thereof

    Sangamo Biosciences, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  20. US 9493609

    N-maleimidyl polymer derivatives

    Nektar Therapeutics · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  21. US 9493544

    Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

    Nektar Therapeutics · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  22. US 9493527

    Compositions and methods for the delivery of nitric oxide

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  23. US 9493526

    Compositions and methods for the delivery of oxygen

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  24. US 9493467

    PI3 kinase antagonists

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.